Insights

Market Expansion Novo Nordisk continues to expand its manufacturing and operational footprint, as evidenced by recent facility expansions in Ireland. This growth indicates ongoing demand for biotechnology products and potential opportunities to supply supporting manufacturing technologies, automation, or facility management solutions.

Brand Visibility The company's strategic marketing initiatives, including high-profile Super Bowl commercials and global event participation, suggest a strong focus on brand awareness. This opens doors for engaging marketing technology, media planning, and digital advertising solutions to further amplify their campaigns.

Leadership & Strategy Recent executive hires in key US and product strategy roles highlight a focus on strengthening market position and portfolio management, presenting opportunities for consulting, analytical tools, and strategic planning services to support growth initiatives.

Legal and Compliance Novo Nordisk's active legal actions against competitors underscore the importance of compliance, legal services, and regulatory solutions, which could support their competitive positioning and risk management efforts.

Financial Growth With revenues between $25 million and $50 million and a funding amount of $100 million, the company shows promising growth potential. This signals opportunities in financial software, investment advisory, and partnership solutions to facilitate scaling and operational efficiency.

Similar companies to Forma Therapeutics (Now Novo Nordisk)

Forma Therapeutics (Now Novo Nordisk) Tech Stack

Forma Therapeutics (Now Novo Nordisk) uses 8 technology products and services including AppNexus, SiteCatalyst, Cart Functionality, and more. Explore Forma Therapeutics (Now Novo Nordisk)'s tech stack below.

  • AppNexus
    Advertising
  • SiteCatalyst
    Analytics
  • Cart Functionality
    E-commerce
  • Knockout.js
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • Office 365
    Office Suites
  • reCAPTCHA
    Security
  • Apache HTTP Server
    Web Servers

Media & News

Forma Therapeutics (Now Novo Nordisk)'s Email Address Formats

Forma Therapeutics (Now Novo Nordisk) uses at least 2 format(s):
Forma Therapeutics (Now Novo Nordisk) Email FormatsExamplePercentage
FLast@formatherapeutics.comJDoe@formatherapeutics.com
89%
FirstLast@formatherapeutics.comJohnDoe@formatherapeutics.com
8%
Last@formatherapeutics.comDoe@formatherapeutics.com
2%
First@formatherapeutics.comJohn@formatherapeutics.com
1%
FLast@novonordisk.comJDoe@novonordisk.com
80%
First.Last@novonordisk.comJohn.Doe@novonordisk.com
11%
FirstL@novonordisk.comJohnD@novonordisk.com
7%
LastF@novonordisk.comDoeJ@novonordisk.com
2%

Frequently Asked Questions

Where is Forma Therapeutics (Now Novo Nordisk)'s headquarters located?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk)'s main headquarters is located at Watertown, Massachusetts 02472 United States. The company has employees across 5 continents, including North AmericaEuropeSouth America.

What is Forma Therapeutics (Now Novo Nordisk)'s phone number?

Minus sign iconPlus sign icon
You can contact Forma Therapeutics (Now Novo Nordisk)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Forma Therapeutics (Now Novo Nordisk)'s stock symbol?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk) is a publicly traded company; the company's stock symbol is FMTX.

What is Forma Therapeutics (Now Novo Nordisk)'s official website and social media links?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk)'s official website is novonordisk.com and has social profiles on LinkedInCrunchbase.

What is Forma Therapeutics (Now Novo Nordisk)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Forma Therapeutics (Now Novo Nordisk) have currently?

Minus sign iconPlus sign icon
As of February 2026, Forma Therapeutics (Now Novo Nordisk) has approximately 193 employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: A. K.Chief Patient Officer, Svp: I. O.Vice President Human Resources: P. S.. Explore Forma Therapeutics (Now Novo Nordisk)'s employee directory with LeadIQ.

What industry does Forma Therapeutics (Now Novo Nordisk) belong to?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk) operates in the Biotechnology Research industry.

What technology does Forma Therapeutics (Now Novo Nordisk) use?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk)'s tech stack includes AppNexusSiteCatalystCart FunctionalityKnockout.jsMicrosoftOffice 365reCAPTCHAApache HTTP Server.

What is Forma Therapeutics (Now Novo Nordisk)'s email format?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk)'s email format typically follows the pattern of FLast@formatherapeutics.com. Find more Forma Therapeutics (Now Novo Nordisk) email formats with LeadIQ.

How much funding has Forma Therapeutics (Now Novo Nordisk) raised to date?

Minus sign iconPlus sign icon
As of February 2026, Forma Therapeutics (Now Novo Nordisk) has raised $100M in funding. The last funding round occurred on Dec 19, 2019 for $100M.

When was Forma Therapeutics (Now Novo Nordisk) founded?

Minus sign iconPlus sign icon
Forma Therapeutics (Now Novo Nordisk) was founded in 2007.

Forma Therapeutics (Now Novo Nordisk)

Biotechnology ResearchMassachusetts, United States51-200 Employees

As of October, 2022, Forma Therapeutics has been acquired by Novo Nordisk.

Section iconCompany Overview

Headquarters
Watertown, Massachusetts 02472 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FMTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $100M

    Forma Therapeutics (Now Novo Nordisk) has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Dec 19, 2019 in the amount of $100M.

  • $25M$50M

    Forma Therapeutics (Now Novo Nordisk)'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $100M

    Forma Therapeutics (Now Novo Nordisk) has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Dec 19, 2019 in the amount of $100M.

  • $25M$50M

    Forma Therapeutics (Now Novo Nordisk)'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.